Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Singapore Adopts Risk-Based Policy For Devices Under Corrective Action

This article was originally published in PharmAsia News

Executive Summary

Singapore's Health Sciences Authority has adopted a revised policy, effective April 18, under which it will apply a new risk-based approach to decide whether or not to allow medical device companies to continue supplying products affected by a field safety corrective action (FSCA) when the action is still in progress.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register